GC
MTEM

Guggenheim Capital’s Molecular Templates, Inc. MTEM Stock Holding History

Guggenheim Capital’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-138
Closed -$9K – 2862
2017
Q2 		$9K Hold
138
– – ﹤0.01% 2812
2017
Q1 		$13K Buy
138
+1
+0.7% +$94 ﹤0.01% 2805
2016
Q4 		$10K Hold
137
– – ﹤0.01% 2881
2016
Q3 		$15K Sell
137
-2
-1% -$275 ﹤0.01% 2847
2016
Q2 		$15K Sell
139
-8
-5% -$573 ﹤0.01% 2828
2016
Q1 		$12K Buy
+147
New +$8.68K ﹤0.01% 2863

Other funds holding MTEM

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Guggenheim Capital's MTEM Position: Q3 2017 in Review

Guggenheim Capital sold out of Molecular Templates, Inc. (MTEM) in Q3 2017, closing a stake of 138 shares — an estimated $9K sold.

Guggenheim Capital first reported a position in MTEM in Q1 2016 and held it in 6 quarters. The position peaked at $15K in Q3 2016. 29 funds tracked by Wall St. Rank hold MTEM as of Q3 2017.

  • Guggenheim Capital reported no remaining Molecular Templates, Inc. position as of Q3 2017 after selling out during the quarter.
  • Guggenheim Capital sold 138 Molecular Templates, Inc. shares in Q3 2017, an estimated $9K.
  • Guggenheim Capital first reported a position in Molecular Templates, Inc. in Q1 2016 and held it in 6 quarters.
  • Guggenheim Capital's Molecular Templates, Inc. position peaked at $15K in Q3 2016.
  • 29 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2017.

Based on Guggenheim Capital's 13F filing for Q3 2017, filed 14 Nov 2017.